申请人:AYDT Ewald M.
公开号:US20110152291A1
公开(公告)日:2011-06-23
Pharmaceutical compositions comprising at least one compound of the formulas (Ia) or (Ib) and a pharmaceutically acceptable carrier wherein the symbols have the following meaning —X- is e.g. and Y being e.g. or the pharmaceutically acceptable salts can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or L-selectin binding.
制药组合物包括至少一种式(Ia)或(Ib)的化合物和一种药学上可接受的载体,其中符号具有以下含义:-X-例如,Y为例如,或药学上可接受的盐可用于调节由E-、P-或L-选择素结合介导的体外和体内结合过程。